Glucagon-like peptide-1 analogue, liraglutide, delays onset and reduces severity of experimental autoimmune encephalitis in Lewis rats

• Päätekijät: Brian DellaValle (Tekijä), Gitte Brix (Tekijä), Birgitte Brock (Tekijä), Michael Gejl (Tekijä), Anne Landau (Tekijä), Arne Møller (Tekijä), Jørgen Rungby (Tekijä), Agnete Larsen (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2016-11-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

AbstractIntroduction: Recent findings indicate that metabolic disturbances are involved in multiple sclerosis (MS) pathology and influence the susceptibility to treatment, directing attention towards anti-diabetic drugs such as metformin and pioglitazone. Liraglutide, a drug of the glucagon-like pep...